A U.S. bankruptcy judge this week approved Metronomic Holdings’ settlement with a creditor, clearing the way for the developer to auction 17 properties in Miami-Dade County and two near Chicago. The ...
Developer Metronomic lost its completed Coconut Grove apartment project in a foreclosure sale, adding to its financial woes of recent years. Wilmington Trust, the largest creditor on GroveHaus, sold ...
Developers who had announced big plans for Coconut Grove before filing for bankruptcy protection earlier this year will now sell many of their holdings in the village and in Little Havana under a ...
Metronomic capecitabine combined with an aromatase inhibitor extends median progression-free survival to 20.9 months compared with 11.9 months for aromatase inhibitor alone in hormone ...
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase ...
Metronomic chemotherapy with capecitabine (Xeloda) plus an aromatase inhibitor (AI) could be a first-line treatment option for some patients with HR-positive, HER2-negative metastatic breast cancer, ...
A new multi-targeted "chemo-switch" drug regimen shows promising anti-tumour activity with manageable side effects in patients with metastatic renal-cell carcinoma (RCC), a disease with few treatment ...
The effects of metronomic chemotherapy plus endocrine therapy have yet to be elucidated through a randomized phase III clinical trial. Randomized clinical trials were conducted at 12 centers in China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results